[1] WU P J,WANG C H,HSIEH M H,et al. The impact of aurora kinase a genetic polymorphisms on cervical cancer progression and clinicopathologic characteristics[J].Int J Med Sci.2021,18(11):2457-2465.
[2] 张双凤,薛秀珍,杨会莉.18F-FDG PET/CT显像联合血清CA19-9对宫颈癌复发及转移的诊断价值分析[J].中国CT和MRI杂志,2019,17(4):102-104.
[3] 覃小敏,邢辉,李琳,等. 血清TAP、bFGF及CDCA5在老年宫颈癌患者中表达水平及其与预后的关系[J].中国老年学杂志,2022,42(12):2893-2896.
[4] HWANG L,BAILEY A,LEA J,et al. Para-aortic nodal metastases in cervical cancer:A blind spot in the international federation of gynecology and obstetrics staging system:Current diagnosis and management[J].Future Oncol,2015,11(2):309-322.
[5] 乐杰.妇产科学[M].7版.北京:人民卫生出版社,2008:175-176.
[6] SIMS T T,KLOPP A H. Intensified systemic therapy regimens in combination with definitive radiation for treatment of cervical cancer[J].Semin Radiat Oncol,2020,30(4):265-272.
[7] 刘亚红,刘艳庆,邱育红. 血管内皮生长因子、糖类抗原125、糖类抗原19-9在宫颈癌中的表达及临床价值[J].癌症进展,2022,20(7):712-715.
[8] JACHNIS A,SŁODKOWSKI M T. The relationship between nutritional status and body composition with clinical parameters,tumor stage,CA19-9,CEA levels in patients with pancreatic and periampullary tumors[J].Curr Oncol,2021,28(6):4805-4820.
[9] 梁志洪,陈结贞,陈永雪,等. 宫颈癌患者血清bFGF及CXCL16含量与癌细胞生长、侵袭的相关性研究[J].海南医学院学报,2017,23(18):2570-2572.
[10] 施琦,杨一君,韩亚青,等. HMGA1、bFGF在宫颈癌患者血清中的表达水平及其意义[J].医学临床研究,2019,36(12):2392-2394.
[11] 周庆红,洛若愚,周晓红,等. Survivin、bFGF、VEGF在宫颈癌组织中的表达及其与临床病理特征的关系研究[J].现代生物医学进展,2018,18(18):3467-3470.
[12] 陈立江,翟梅娟. 宫颈癌组织中Galectin-3、CA19-9水平与临床病理特征的相关性[J].中国妇幼保健,2019,34(22):5298-5301.
2023, Vol. 40 
